Holen Sie sich die Stockscreener-App
34.91
2.10%
-0.79
Pacs Group Inc Aktie (PACS) Neueste Nachrichten
Momentum Shift: Can PACS Group Inc reach resistance levels soon2026 Earnings Surprises & Daily Profit Maximizing Tips - baoquankhu1.vn
Jergensen Joshua, president & COO of PACS Group, sells $1.24 million in stock - Investing.com
PACS: Record 2025 growth, strong financials, and robust M&A pipeline position the company for 2026 - TradingView
Zacks Industry Outlook Highlights BrightSpring Health Services, InnovAge and PACS - TradingView
PACS Group, Inc. (PACS) Stock Price, News, Quote & History - Yahoo! Finance Canada
PACS Group, Inc. to Present at the Oppenheimer 36th Annual Healthcare MedTech & Services Conference on March 17, 2026 - The Joplin Globe
Annual Healthcare MedTech & Services Conference on March 17, 2026 - Business Wire
3 Medical Service Industry Stocks Set to Counter Workforce Issues - TradingView
PACS Group (PACS) price target increased by 17.62% to 36.89 - MSN
PACS Group adds former CMS official Patrick Conway to board By Investing.com - Investing.com Nigeria
A Look At PACS Group (PACS) Valuation After Record Earnings And Zacks Rank Upgrade - simplywall.st
Live PACS Group, Inc. (PACS) Technical Analysis - Traders Union
Technical Reactions to PACS Trends in Macro Strategies - Stock Traders Daily
PACS Group (PACS) Insider Trading Activity 2026 $PACS - MarketBeat
Does PACS Group’s (PACS) Optum CEO Board Addition Reframe Its Value-Based Care Ambitions? - Sahm
PACS Group Earnings Call Highlights Profitable, Disciplined Growth - The Globe and Mail
PACS vs. MEDP: Which stock is the better value option? - MSN
PACS Group, Inc. (PACS) Raised to Strong Buy: The Reasons Explained - Bitget
PACS Group, Inc. (PACS) Upgraded to Strong Buy: Here's Why - Yahoo Finance
Does PACS Group, Inc. (PACS) have the potential to rally 25.45% as Wall Street analysts expect? - MSN
Is PACS Group (PACS) Pricing Reflect Its Recent Share Price Pullback And Growth Hopes - Yahoo Finance
Mark Hancock - Forbes
[144] PACS Group, Inc. SEC Filing - Stock Titan
PACS Group, Inc. (PACS) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
2026-03-08 | PACS Group, Inc. (PACS) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation | NYSE:PACS | Press Release - Stockhouse
Pacs (PACS) Hits 52-Week High on Q3 Blowout - MSN
PACS Group (NYSE:PACS) Upgraded by Zacks Research to "Strong-Buy" Rating - MarketBeat
PACS Group, Inc. 8-K Filing: Company Information, Common Stock Trading Details, and SEC Compliance Disclosure (March 2026) - Minichart
PACS Group adds former CMS official Patrick Conway to board - Investing.com
PACS Group Appoints Patrick Conway to Board of Directors - TipRanks
Director at PACS Group (PACS) receives 3,497 restricted stock units grant - Stock Titan
Patrick Hugh Conway joins PACS Group (PACS) insider roster with Form 3 - Stock Titan
Bronstein, Gewirtz & Grossman, LLC Encourages PACS Group, Inc. (PACS) Shareholders to Inquire about Securities Investigation - ACCESS Newswire
PACS vs. MEDP: Which Stock Is the Better Value Option? - Bitget
PACS Group, Inc. Appoints Dr. Patrick Conway, MD, MSc to Board of Directors - 01net
Does PACS Group, Inc. (PACS) Have the Potential to Rally 25.45% as Wall Street Analysts Expect? - Finviz
PACS Group Appoints Dr. Patrick Conway to Board - National Today
Pacs Group, Inc. appoints Dr. Patrick Conway, MD, MSc to board of directors - marketscreener.com
Best Momentum Stock to Buy for March 5th - Yahoo Finance Australia
Best Value Stock to Buy for March 5th - Yahoo Finance
A Look At PACS Group (PACS) Valuation After Record 2025 Results And New 2026 Guidance - simplywall.st
5 Analysts Assess PACS Group: What You Need To Know - Benzinga
PACS Stock Receives Updated "Buy" Rating from UBS Today | PACS S - GuruFocus
PACS Group (NYSE:PACS) Price Target Raised to $44.00 at UBS Group - MarketBeat
UBS Adjusts PACS Group Price Target to $44 From $42, Maintains Buy Rating - marketscreener.com
PACS Group Inc (PACS) Shares Up 2.9% on Mar 4 - GuruFocus
Oppenheimer Adjusts Price Target on PACS Group to $42 From $40, Maintains Outperform Rating - marketscreener.com
PACS Group (NYSE:PACS) Price Target Raised to $42.00 at Oppenheimer - MarketBeat
Bronstein, Gewirtz & Grossman, LLC Is Investigating PACS Group, Inc. (PACS) And Encourages Shareholders to Connect - ACCESS Newswire
PACS Group (PACS) awards 30,000 restricted stock units to Chief Compliance Officer - Stock Titan
PACS Group (NASDAQ: PACS) awards 25,000 RSUs to HR chief - Stock Titan
PACS (PACS) logs Form 3 insider status for Chief Compliance Officer - Stock Titan
PACS Group (PACS) HR chief Bingham Trent Dean files initial Form 3 - Stock Titan
PACS Group, Inc. (PACS) Stock Analysis: A Promising 20.63% Upside in the Healthcare Sector - DirectorsTalk Interviews
PACS Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
PACS Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
PACS : Initial Statement of Beneficial Ownership (Form 3) - marketscreener.com
PACS Group Receives 'Moderate Buy' Rating from Analysts - National Today
1.87%
0.66%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):